Compare GLMD & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLMD | HTCR |
|---|---|---|
| Founded | 2000 | 2009 |
| Country | Israel | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 3.4M |
| IPO Year | 2013 | 2022 |
| Metric | GLMD | HTCR |
|---|---|---|
| Price | $0.57 | $3.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 284.6K | 95.4K |
| Earning Date | 05-21-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 87.84% |
| EPS Growth | N/A | ★ 414.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,407,229.00 |
| Revenue This Year | N/A | $123.26 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 39.19 |
| 52 Week Low | $0.41 | $0.15 |
| 52 Week High | $2.34 | $3.97 |
| Indicator | GLMD | HTCR |
|---|---|---|
| Relative Strength Index (RSI) | 46.03 | 50.67 |
| Support Level | $0.55 | $2.80 |
| Resistance Level | $0.69 | $3.86 |
| Average True Range (ATR) | 0.09 | 0.38 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 47.83 | 23.27 |
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. The company focuses on the development of Aramchol for combination therapy for GI oncological indications. The company is actively pursuing opportunities in the biotech and medtech spaces to expand and diversify its product pipeline targeting GI, cardiometabolic indications and other product candidates.
HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.